Abstract
Dynamic contrast-enhanced CT imaging techniques (perfusion CT) enable clinicians to evaluate the functional blood supply to a tissue of interest or organ. From the subsequent changes in enhancement following intravenous administration of an iodinated contrast agent, qualitative and quantitative parameters may be assessed that describe the enhancement time curves obtained or quantify regional perfusion, blood volume and microcirculatory changes, respectively. These parameters may provide prognostic or predictive information to the clinician and enable treatment effects on the vasculature to be assessed. Its clinical use has increased in recent years due to a combination of factors: technological advances in acquisition and post-processing methods that have facilitated its clinical implementation and a perceived clinical need, related to the use of therapeutic interventions in ischemic vascular disease and oncology. This chapter discusses the principles of perfusion CT techniques, clinical protocols and clinical application in oncology.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- AIF:
-
Arterial input function
- BF:
-
Regional blood flow
- BV:
-
Blood volume
- CT:
-
Computed tomography
- CTDIvol :
-
CT Dose Index by volume
- DCE-CT:
-
Dynamic contrast enhanced CT
- DLP:
-
Dose length product
- DNA:
-
DeoxyriboNucleic Acid
- EF:
-
Extraction Fraction
- 18F-FDG:
-
Fluoro-deoxy-glucose
- HCC:
-
Hepatocellular carcinoma
- K trans :
-
Transfer constant
- MTT:
-
Mean transit time
- MVD:
-
Microvessel density
- NSCLC:
-
Non small cell lung cancer
- PET:
-
Positron emission tomography
- PS:
-
Permeability surface area product
- ROI:
-
Region of interest
- VEGF:
-
Vascular endothelial growth factor
References
Miles KA, et al. Experimental Cancer Medicine Centre Imaging Network Group. Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography. Eur Radiol. 2012;22:1430–41.
Folkman J. The role of angiogenesis in tumour growth. Semin Cancer Biol. 1992;3:65–71.
Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumourigenesis. Cell. 1996;86:353–64.
Goh V, et al. Assessment of the metabolic flow phenotype of primary colorectal cancer: correlations with microvessel density are influenced by the histological scoring method. Eur Radiol. 2012;22:1687–92.
Yi CA, et al. Solitary pulmonary nodules: dynamic enhanced multidetector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology. 2004;233:191–9.
Li Y, et al. Peripheral lung carcinoma: correlation of angiogenesis and first-pass perfusion parameters of 64-detector row CT. Lung Cancer. 2008;61:44–53.
Ma SH, et al. Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression. BMC Cancer. 2008;8:186.
Sauter AW, et al. Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT. J Nucl Med. 2012;53:521–9.
Spira D, et al. Assessment of tumor vascularity in lung cancer using Volume Perfusion CT (VPCT) with histopathologic comparison: a further step toward an individualized tumor characterization. J Comput Assist Tomogr. 2013;37:15–21.
Tateishi U, et al. Lung tumors evaluated with FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism. J Comput Assist Tomogr. 2002;26:185–90.
Wang JH, et al. Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. AJR Am J Roentgenol. 2006;186:1423–30.
Reiner CS, et al. Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers. Invest Radiol. 2013;48:183–91.
Yao J, et al. Gastric adenocarcinoma: can perfusion CT help to noninvasively evaluate tumor angiogenesis? Abdom Imaging. 2011;36:15–21.
Goh V, et al. Colorectal tumor vascularity: quantitative assessment with multidetector CT – do tumor perfusion measurements reflect angiogenesis? Radiology. 2008;249:510–7.
Hattori Y, et al. Enhancement patterns of pancreatic adenocarcinoma on conventional dynamic multi-detector row CT: correlation with angiogenesis and fibrosis. World J Gastroenterol. 2009;15:3114–21.
Mandeville HC, et al. Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia. Radiology. 2012;264:581–9.
Tacelli N, et al. Assessment of non-small cell lung cancer perfusion: pathologic-CT correlation in 15 patients. Radiology. 2010;257:863–71.
Saddi KA, et al. Large deformation registration of contrast-enhanced images with volume preserving constraint. In: Pluim JPW, Reinhardt JM, editors. Proceedings of SPIE: medical imaging 2007—image processing, vol. 6512. Bellingham: International Society for Optical Engineering; 2007. p. 651203.
Goh V, et al. Radiation dose from volumetric helical perfusion CT of the thorax, abdomen or pelvis. Eur Radiol. 2011;21:974–81.
Goh V, et al. Reproducibility of dynamic contrast-enhanced MRI: why we should care. Radiology. 2013;266:698–700.
Cenic A, et al. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral flow maps. AJNR Am J Neuroradiol. 2000;21:462–70.
Nabavi DG, et al. Quantitative assessment of cerebral hemodynamics using CT: stability, accuracy, and precision studies in dogs. J Comput Assist Tomogr. 1999;23:506–15.
Goh V, et al. Quantitative assessment of tissue perfusion using MDCT: comparison of colorectal cancer and skeletal muscle measurement reproducibility. AJR Am J Roentgenol. 2006;187:164–9.
Ng QS, et al. Quantitative assessment of lung cancer perfusion using MDCT: does measurement reproducibility improve with greater tumor volume coverage? AJR Am J Roentgenol. 2006;187:1079–84.
Purdie TG, et al. Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumor. Phys Med Biol. 2001;46:3161–75.
Ng QS, et al. Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements. Radiology. 2006;239:547–53.
Erasmus JJ, et al. Inter- and intra-observer variability in measurement of non-small cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol. 2003;21:2574–82.
Goh V, et al. Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest. Radiology. 2008;247:726–32.
Sanelli PC, et al. Reproducibility of postprocessing of quantitative CT perfusion maps. AJR Am J Roentgenol. 2007;188:213–8.
Fiorella D, et al. Assessment of the reproducibility of postprocessing dynamic CT perfusion data. AJNR Am J Neuroradiol. 2004;25:97–107.
Bisdas S, et al. Functional CT of squamous cell carcinoma in the head and neck: repeatability of tumor and muscle quantitative measurements, inter- and intra-observer agreement. Eur Radiol. 2008;18:2241–50.
Goh V, et al. Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology? Invest Radiol. 2012;47:2–4.
Lissoni P, et al. Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer. Int J Biol Markers. 2000;15:308–11.
Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307:58–62.
Hinnen P, Eskens FA. Vascular disrupting agents in clinical development. Br J Cancer. 2007;96:1159–65.
Garcia-Barros M, et al. Tumour response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003;300:1155–9.
Chen G, et al. Computed tomography perfusion in the evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol. 2008;14:5738–43.
Parulekar WR, Eisenhauer EA. Phase I trial design for solid tumour studies of targeted non-cytotoxic agents: theory and practice. J Natl Cancer Inst. 2004;96:990–7.
Hurwitz H, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335–42.
Escudier B, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 2007;356:125–34.
Motzer RJ, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007;356:115–24.
Llovet JM, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378–90.
Sahani DV, et al. Advanced hepatocellular carcinoma: CT Perfusion of liver and tumor tissue-initial experience. Radiology. 2007;243:736–43.
Li XS, et al. The value of perfusion CT in predicting the short term response to synchronous radiochemotherapy for cervical squamous cancer. Eur Radiol. 2012;22:617–24.
Tateishi U, et al. Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma. Cancer. 2002;95:835–42.
Goh V, et al. Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study. Eur Radiol. 2009;19:79–89.
Hayano K, et al. Perfusion CT can predict response to chemoradiation therapy and survival in oesophageal squamous cell carcinoma: initial results. Oncol Rep. 2007;18:901–8.
Hayano K, et al. Quantitative measurement of blood flow using perfusion CT for assessing clinicopathological features and prognosis in patients with rectal cancer. Dis Colon Rectum. 2009;52:1624–9.
Hermans R, et al. Tumor perfusion rate determined non-invasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57:1351–6.
Haider MA, et al. Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements. Int J Radiat Oncol Biol Phys. 2005;62:1100–7.
Fournier LS, et al. Metastatic renal carcinoma: evaluation of anti-angiogenic therapy with dynamic contrast enhanced CT. Radiology. 2010;256:511–8.
Han KS, et al. Pretreatment assessment of tumor enhancement on contrast-enhanced computed tomography as a potential predictor of treatment outcome in metastatic renal cell carcinoma patients receiving antiangiogenic therapy. Cancer. 2010;116:2332–42.
Bisdas S, et al. Response and progression-free survival in oropharynx squamous cell carcinoma assessed by pretreatment perfusion CT: comparison with tumor volume measurements. AJNR Am J Neuroradiol. 2009;30:793–9.
Bisdas S, et al. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys. 2009;73:1313–8.
Jiang T, et al. Monitoring response to antiangiogenic treatment and predicting outcomes in advanced HCC using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST). Invest Radiol. 2012;47:11–7.
Wang J, et al. Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy. AJR Am J Roentgenol. 2009;193:1090–6.
Hegenscheid K, et al. Assessing early vascular changes and treatment response after laser-induced thermotherapy of pulmonary metastases with perfusion CT: initial experience. AJR Am J Roentgenol. 2010;194:1116–23.
Ippolito D, et al. Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor. World J Gastroenterol. 2010;16:5993–6000.
Goh V, et al. The flow-metabolic phenotype of primary colorectal cancer: assessment by integrated 18F-FDG PET/perfusion CT with histopathologic correlation. J Nucl Med. 2012;53:687–92.
Ippolito D, et al. Feasibility of perfusion CT technique integrated into conventional (18)FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study. Eur J Nucl Med Mol Imaging. 2013;40:156–65.
Sauter AW, et al. Correlation between [(18)F]FDG PET/CT and volume perfusion CT in primary tumours and mediastinal lymph nodes of non-small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2013;40:677–84.
Delrue L, et al. Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging. J Comput Assist Tomogr. 2011;35:434–8.
Kandel S, et al. Whole-organ perfusion of the pancreas using dynamic volume CT in patients with primary pancreas carcinoma: acquisition technique, post-processing and initial results. Eur Radiol. 2009;19:2641–6.
Klauss M, et al. Computed tomography perfusion analysis of pancreatic carcinoma. J Comput Assist Tomogr. 2012;36:237–42.
Delrue L, et al. Tissue perfusion in pathologies of the pancreas: assessment using 128-slice computed tomography. Abdom Imaging. 2012;37:595–601.
Tsuji Y, et al. Perfusion CT is superior to angiography in predicting pancreatic necrosis in patients with severe acute pancreatitis. J Gastroenterol. 2010;45:1155–62.
Arikawa S, et al. Assessment of chronic pancreatitis: use of whole pancreas perfusion with 256-slice computed tomography. Pancreas. 2012. [Epub ahead of print].
Lu N, et al. 64-slice CT perfusion imaging of pancreatic adenocarcinoma and mass-forming chronic pancreatitis. Acad Radiol. 2011;18:81–8.
Swensen SJ, et al. Lung nodule enhancement at CT: multicenter study. Radiology. 2000;214:73–80.
Zhang M, Kono M. Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology. 1997;205:471–8.
Sitartchouk I, et al. Computed tomography perfusion using first pass methods for lung nodule characterization. Invest Radiol. 2008;43:349–58.
Ohno Y, et al. Differentiation of malignant and benign pulmonary nodules with quantitative first-pass 320-detector row perfusion CT versus FDG PET/CT. Radiology. 2011;258:599–609.
Fournier LS, et al. Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent. Eur Radiol. 2004;14:2125–33.
Ippolito D, et al. Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations. J Comput Assist Tomogr. 2008;32:855–8.
Ippolito D, et al. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization. Eur J Radiol. 2010;73:148–52.
Ippolito D, et al. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging. Eur Radiol. 2012;22:803–11.
Goh V, et al. Differentiation between diverticulitis and colorectal cancer: quantitative CT perfusion measurements versus morphologic criteria–initial experience. Radiology. 2007;242:456–62.
Trojanowska A, et al. Squamous cell cancer of hypopharynx and larynx – evaluation of metastatic nodal disease based on computed tomography perfusion studies. Eur J Radiol. 2012;81(5):1034–9.
Bisdas S, et al. Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging. AJNR Am J Neuroradiol. 2008;29:1376–81.
Veit-Haibach P, et al. Combined PET/CT-perfusion in patients with head and neck cancers. Eur Radiol. 2013;23:163–73.
Liu Y, et al. Accuracy of computed tomography perfusion in assessing metastatic involvement of enlarged axillary lymph nodes in patients with breast cancer. Breast Cancer Res. 2007;9:R40.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Westerland, O., Goh, V. (2014). Perfusion CT: Principles, Technical Aspects and Applications in Oncology. In: Luna, A., Vilanova, J., Hygino da Cruz Jr., L., Rossi, S. (eds) Functional Imaging in Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40412-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-40412-2_15
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40411-5
Online ISBN: 978-3-642-40412-2
eBook Packages: MedicineMedicine (R0)